MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals

Evelia Leal-Ugarte1, Melva Gutiérrez-Angulo, Nelly M Macías-Gómez

  • 1Unidad Academica de Ciencias de la Salud y Technologia, Universidad Autonoma de Tamaulipas, Sendero Nacional km 3, Matamoros, Tamaulipas, Mexico, CP 87349.

Human Biology
|March 26, 2009
PubMed

Insights

The MDR1 C3435T polymorphism does not appear to increase the risk of childhood acute lymphoblastic leukemia (ALL) in Mexican children. Genetic variations in this gene are not a significant factor for ALL development in this population.

Area of Science:

  • Genetics
  • Pediatric Oncology

Background:

  • The MDR1 gene plays a crucial role in drug transport.
  • Polymorphisms in the MDR1 gene, such as C3435T, may influence susceptibility to various diseases, including cancers.
  • Childhood acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy.

Purpose of the Study:

  • To investigate the association between the MDR1 C3435T polymorphism and the risk of developing childhood ALL in a Mexican population.
  • To compare genotype and allele frequencies between children with ALL and healthy controls.

Main Methods:

  • Genotyping of 107 children with ALL and 111 healthy children for the MDR1 C3435T polymorphism.
  • Utilizing the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method for genotyping.
  • Statistical analysis of genotype and allele frequencies.

Main Results:

  • No significant differences in MDR1 C3435T allele or genotype frequencies were observed between Mexican children with ALL and healthy controls (p > 0.176 for alleles, p > 0.255 for genotypes).
  • Allele frequencies in Mexican healthy subjects differed significantly when compared to other global populations, suggesting potential ethnic variations.
  • The CT and TT genotypes were not found to be associated with an increased risk of childhood ALL in this cohort.

Conclusions:

  • The MDR1 C3435T polymorphism is unlikely to be a risk factor for childhood ALL in the studied Mexican population.
  • Observed differences in allele frequencies among healthy Mexican subjects and other populations warrant further investigation into genetic background diversity.
  • Future research should explore other genetic or environmental factors contributing to childhood ALL in diverse ethnic groups.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...